Retinoids exert their biologic effects through two families of nuclear receptors, retinoic acid receptors (RARs) and retinoid X receptors (RXRs), which belong to the superfamily of steroid/thyroid hormone nuclear receptors. By using a subtraction hybridization approach, we have identified a eDNA sequence TIG2 (Tazarotene-induced gene 2), whose expression is up-regulated by the treatment of skin raft cultures by an RAR /3/y-selective anti-psoriatic synthetic retinoid tazarotene {AGN 190168/ethyl 6-[2-(4,4-dimethylthiochroman-6-yl)-ethynyl] nicotinate}. The retinoid-mediated up-regulation in the expression of TIG2 was confirmed by Northern blot analysis. Upon sequencing, TIG2 was found to be a eDNA whose complete sequence was not in the GenBank and EMBL data bases. The TIG2 eDNA is 830 bp long and P harm acologic and physiologic retinoid signals in skin are transdu ced through two families of nuclear receptors, namely, retinoic acid receptors (RARa , {3, and y) and retinoid X receptors (RX R a, {3 , and y) (C hambon , 1994 (C hambon , : Mangelsdorf et a/, 1994 Boe hm et al, 1995; Nagpal and C handraratna, 1996) . RARs, which belong to the superfamily of steroid/th yroid /vitamin D 3 nuclear receptors, readily h eterodimerize with RX. R.s in IJilro (for re ferences see, Nagpal and Chandraratna, 1996) and function as such i11 LJiiJo (Nagpal et a/, 1993) . RARs are liga nd-dependent transcription factors that activate the expression of retinoid-responsive genes by cooperative action of their activation functions, AF-1 (ligandindependent activation function) , and .AF-2 (ligand-dependent activation fi.mction) (Nagpal et al, 1992 (Nagpal et al, , 1993 . R etinoids have been extensively used for the treatment of vatious no nmalignant (psoriasis and acne), and m alignant (squamous cell carcinoma, actinic keratoses, basal ceU carcinoma , and Kaposi's sarcoma) skin diseases, and th ey hold significant potential as a therap eutic modality in vat;ous epithelial cancers (Peck and DiGiovanna, 1994; Boehm et al, 1995; N agpal and C handraratna, 1996) . Despite their therapeutic effi cacy in various dermatologic di seases, the mol ecular basis of retinoid action in skin is poorly understood. Various genes whose Mrumscript received N ovember l 4, 1996; revised March 6, 1997; accepted fo r publi cation M arch 17 , 1997. Reprint requests to: Dr. Stmil Nagpal or Dr. R os hantha A.S. C h andraratna, R etin oid R esea rch , D epartmen ts of Biology and C h em.i stry, AJ! ergan , Inc., Irvine, CA 92713 .
Abbrevia tions: RA, retinoic acid ; RAR, retinoic acid receptor; R.XR , retino ic X receptor; T IG1, tazarotene indu ced gen e 1; T IG2 , tazarotene induced gene 2; VDR, vitamin D 3 receptor. encodes a putative protein product of 164 amino acids. TIG2 is neither expressed nor induced by tazarotene in primary keratinocyte and fibroblast cultures. Thus, TIG2 is expressed and induced by tazarotene only when keratinocytes and fibroblasts form a tissue-like 3-dimensional structure. We further demonstrate that RAR-specific retinoids increase TIG2 mRNA levels. In contrast, neither RXR-specific retinoids nor 1,25-dihydroxyvitamin D 3 increased TIG2 levels. Finally, we demonstrate that TIG2 is expressed at high levels in nonlesional psoriatic skin but at lower levels in the psoriatic lesion and that its expression is up-regulated in psoriatic lesions after topical application of tazarotene. Kq words: vetinoic acid l'eceptovlpsoriasislsubtmctive l1ybYidiz atiou. J Invest Dermatol 109: [91] [92] [93] [94] [95] 1997 expression is induced i.n cell culture sys tem s by retinoids have b een described. Of these, cellular retinoic acid binding protein II (CR.ABPII) is the only marker whose expression is induced b y retinoic acid (R.A) in normal skin . In contrast, CR.ABPII expression is downregulate d by RA in submet·ged keratinocyte cultures (El d er and Cromie, 1993) , and it is also overexpressed in psoriasis (Didietjean et a/, 1991), a h yper-proliferative and inflammatory condition of skin (Krueger and Duvic, 1994 ) that can be treated by retinoids (Esgleyes-Ribot et a!, 1994; Weinstein, 1996) . The increased levels of CR.ABPII i.n psodatic plaques indicates that it may not be a useful efficacy marker of retinoid action in psmiatic lesiom . In addition , several lines of evid en ce suggest that CR.ABPli fimctions to modulate retinoid action by sequestering RA away fi·om the nucle us ru1d by enhancing RA m etabolism (Bo ylan and Gudas, 1991; Fiorella and Napoli, 1991) .
To further un.d erstru1d the molecular m echanisms of retinoid therapeutic action in skin , we so ught to identify genes whose expression is induced in a 3-dimensional skin culture system (skin rafts) by an anti-psoriatic synthetic retinoid, tazarotene (AGN 190168) (W einstein, 1996) . Since tazarotene is topically efFective in the treatm ent of psoriasis, studying its mechrulism of action would provide insight into how retinoids affect the disease. Recently, by usin g a subtractive hybridization approach in ski n ra fts , we identifi. e d a novel gene, ta zaro tene-induced gene 1 (TIG l), whose expression was induced in skin rafts and psoriatic lesions b y tazaroten e (Nagpal et a/, 1996) . With a similar strategy for identification of difFerentially expressed transcripts, we have now identified another novel gen e, tazarotene-induced gene 2 (TIG2) , whose expression is up-regulated by this anti-ps01;atic retinoid in skin rafts. Interestingly, unlike TIG1, TJG2 is not expressed in 0022-202X/97/S10.50 • Copyright © 1997 by The So iety fo r Investigative D ermatology, lnc. 91 2-dimensional cultures of keratinocytes and fibroblasts. The basal and retinoid-induced expression of TIG2 is observed only when keratinocytes and fibroblasts form a tissue-like structure as in skin rafts and psoriatic lesions. We also demonstrate that T IG 2 is induced by RAR-specific but not significantly by RXR-specific retinoids and 1 ,25-dihydro:x:yvitamin D 3 . Finally, we demonstrate that TIG2 is expressed at high levels in nonlesional psoriatic skin but only at lower levels in the psoriatic lesion and that topical app lication of tazarotene to psoriatic plaques results in a rapid upregulation of TIG2 expression.
MATEIUALS AND METHODS

Skin Rafts and Primary Cultures of Keratinocytes and Fibroblasts
Normal skin raft cultures (model ZK 1300, Advanced Tissue Sciences, San Diego, CA) are 3-di.mensional models of human skin tissues that have demnl, epidermal, and comified layers. T hese skin rafts were made by the manufacturer by seeding neonatal fibrob lasts (pooled from 10 donors) onto a nylon mesh, which gave rise to a dermal tissue. Keratinocytes seeded on top of the dennal tissue differentiated into multilayered epidermis consisting ofbasal, spinous, and gran ular layers and stratum cornew11. Primary cultures of foreskin keratinocytes and fibrob lasts were purchased (Cionetics, San Diego, CA).
Subtractive Hybridization Skin raft cu ltures were either mock-treated or treated with the retinoid tazarotene (1 p.M) on days l and 3 and harvested on day 4 for total RNA preparation as described previously (Nagpal et al, 1996) . eDNA prepared from tazarotene-treated skin raft cultures was directionally cloned into Sali-Noti sites ofpSPORT-1 (Life Technologies, Gaithersburg, MD) and si ngle-stranded DNA (ssDNA) was prepared from 10 6 transformants as described previously (Li et al, 1994; Nagpal et al, 1996) . Another directional eDNA library was constructed in Sail-Not! sites of pSPORT-2 (Life Technologies, Gaithersburg, MD), by using eDNA from mock-treated skin rafts, linearized w ith Sail and i11 vitro-transcribed in the presence ofbiot:in-14-CTP as described (Li el al, 1994) . pSPORT-1. ssDNA was blocked with a Noll-oligo primer 5'-GCGGCCGCCCT 15 -3' by incubation at 70°C for 20 min with 600 p.M dTTP and Taq DNA polymerase. Poly(dA)-blocked ssDNA (600 ng) wa s h ybridized w ith biot:inylated RNA (80 p.g) in 2 X hybridization buffer (80% formamide, 100 mM N-(2-hydroxyethyl)piperazil)e-N' -(2-ethanesulfonic acid), pH 7 .5, 2 mM ethylenediamine tetraacetic acid, 0.2')'(, sodium dodecyl su lfate) for 24 h at 42°C with shaking (200 rpm). The control experiment contained all the components except biotinylated RNA. After hybridization, streptavidin (25 p.g) was added <md the 1nixture was in cu bated at .room temperature (5 min). Common ssDNA/RNA sequences were removed by phenol/chloroform extraction (five times), and unhybridized ssDNA was precipitated and electroporated into DH12S (Life Tecllllo. logies, Gaithersb urg, MD) cells.
Retinoids All-tra11s-retinoi c acid (RA) and 1,25-dihydrox-yvitamin D 3 were purchased (Sigma , St. Louis, MO, and Calbi ochem, La Jolla , CA). Tazarotene {ethyl 6-[2-( 4,4-dimethylthiochroman-6-yl)-ethynyl) nicotinate) , SR 11217 {4- [1-(5,6, 7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl Northern Blot Hybridization For northern blot hybridization , total RNA (10 (.Lg) was electroph oresed on 1% agarose-1.1 M formalde hyde gels, transferred to Nytran, and probed with labeled eDNA probes at 42°C for 18 h. The most stringent wash was at 65°C in 0.1 X SSPE (0.18 M NaCl, 10 mM sodi um phosphate, pH 7.4, l mM ethylenediamine tetraacctic acid)/1% sodium dodecyl su lfate for 30 min.
In Situ Hybridization I11 situ hybridization was perform ed on paraffinembedded paraformaldehyde-ftxed sections by using Geni us kit (Boehringer Mrumheim, Indiru1apolis, IN). Proteinase K (2 .5 (.Lg per ml) digestion was carried on for 30 min and hybridization with digoxigenin-labeled anti-sense probe (0 .4 ng per ml) was performed at 44°C. Nonspecific binding was blocked with normal sheep serum (2'V.,) , and specific binding was detected by incubation (3 h) with alkaline phosphatase-conjugated ant:i-digoxigenin antibody followed by a 4-h incubation with n.itrob lue tetrazolium substrate at 37°C. Sense probes were used in parallel as negative controls and showed no background staining.
RESULTS
Identification of a Novel Retinoid-Responsive Gene, TIG2, by Subtraction Hybridization Tazarotene (AGN 190168), an RAR{3/ ')'-selective retinoid, is topically effective in the treatment of eDNA clone B1, obtained fi·om subtracted eDNA lib rary, was confirmed to be tazarotene-responsive by northern blot hybridization. Total RNA (10 (.Lg) fi·om mock-treated or tazarotene-treated skin raft cu ltures was subjected to northern blot hybridization. GAPDH and B1 sequen ces were detected with labeled eDNA probes. The northern blot signals, quantified in terms of total volume (an arbitrary unit) by Phosphorlmager (M.olecul ar Dynamics , Sunnyvale , CA), are also presented. T he overnight expos ure of the blot in the Phosphorlmager screen is presented. The message level ofB 1 eDNA clone was induced 4-fold after tazarotene treatment of skin raft cu ltures.
psoriasis (Esgleyes-Ribot et al, 1994; Weinstein, 1996) , a skin disease characterized by keratinocyte hyper-proliferation and infiltration of immnne cells into epidermis and dermis. To identify tazarotene-responsive genes in skin, we u sed a subtraction hybridization procedure (Li eta/, 1994; Nagpal eta/, 1996) to isolate differentially regulated genes from skin raft cultures. Differentially expressed genes in tazarotene-treated skin rafts, isolated after subtraction of common eDNA sequences b etween vehicle-treated and tazarotene-treated skin rafts, were analyzed by northern blot hybridi zation . The expression of one of the subtracted eDNA clones, B 1, was induced after tazarotene treatment of skin rafts (Fig  1) . The b lot was also probed with labeled G ly ceraldehyde-3-phosphate dehydrogenase (GAPDH) (a housekeeping gene) eDNA to ensure that equal quantities of control and retinoid-treated RNA were used in the northern b lot ana lysis (Fig 1) . Quantitation of the northern message showed a 4-fold increase in B1 expression after tazarotene treatrnent. Upon sequencing, Bl was found to be 830 bp in le ngth, contained an open reading frame from 157 to 648 bp, and coded for a putative protein product of 164 amino acids (Fig 2) . The ATG (157-159 bp) protein initiation codon was confirmed by the presence of an in-frame stop codon (TGA) 12 bp upstream of the ATG codon (Fig 2A) . It had a canonical poly(A) signal (5'-AATAAA-3') at bp 750 and a lo ng poly(A) tail starting at bp 769 (Fig 2) . Homology search es from DNA (GenBank and EMBL) datab ases showed significant homology to a 176-bp mRNA sequ ence (GenBank accession number, L07329) isolated from retina l pigment epith elial cells (Fig 3A) . Further homology search es from protein (Swiss-Prot) database did not show identity to known protein seq uen ces. W e therefore conclude that Bl is a novel eDNA seque nce. Subsequently, anotl1er eDNA clone, B13, was identified from the same library as a tazarotene-induced gen e and upon sequencing was found to be identical to Bl. Because we have previously reported a tazarotene-induced ge n e as TIGl, B1 will h ereafter b e referred to as tazarotene-induced gene 2, or TIG2. A hydrophobic stretch of 20 am.ino acids in the N-terminal region of the protein (Fig 3B) indicated that the TIG2 p r oduct might be a membrane-associated protein. TIG2 also contained putative signals for casein kinase II phosphorylation (amino acids 50-53 and 54-57), myristylation (amino acids 16-21 and 29-34), and protein kinase C phosphorylation (amino acids 76-78). These putative motifs were identified by MacDNASIS PROSITE program. T he consensus seq u ences used for searching phosphorylation sites were (S/T)-X-X-(D/E) and (S/T)-X-(R/K), respectively, for casein kinase II and protein kinase C phosphorylation motifs (MacDNASIS). Interestingly, TIG2 was not up-regulated by tazarotene or RAin 2-dimensional cu ltures ofkeratinocytes (Fig 4A) or fibroblasts (Fig 4B) . GAPDH contro ls for RNAs are also shown in Fig 4A and B for keratinocytes and fibrob lasts, respectively. Also, TIG2 was expressed exclusively in the epidermis of nonlesional and lesional psoriatic skin and was up-regulated in psoriatic lesions by tazarotene treatment (vide s11pra, Fig 5) . These findings suggested two plausible reasons why TIG2 was not retinoid-inducible in keratinocyte and fibroblast cultures: (i) the retinoid might induce a fibroblast-specific factor that then up-regulates TIG2 expression in keratinocytes or (ij) TIG2 mjght be expressed and induced in a retinoid-dependent manner only when keratinocytes and fibroblasts form a "tissue" structure as in skjn rafts and skin. To test the fu·st possibility, keratinocytes were treated with tazarotene in the presence of fibroblast-conditioned m edium. These keratinocytes also exhibited neither basal nor tazarotene-induced expression of TlG2 (Fig 4C) , therefore ruling out the possibility of a retinoidresponsive fibroblast-specific factor in the induction ofTIG2. The GAPDH contro l for the keratinocytes grown in fibrob last-conditioned medium is also shown (Fig 4C) . TIG2 Responds to RAR but Not to RXR or Vitamin 0 3 Receptor (VDR) Agonists Tazaroten e (AGN 190168) activates gene expression only through RARs and not through RXH.s (Nagpal et al, 1995 (Nagpal et al, , 1996 . Further, AGN 190168 is RAR{3/'yselective and exhibits only weak transactivation through RARa (Nagpal et a/, 1995) . In contrast, SR 11217 and SR 11237 are RXR-specific and do not activate gene expression through RARs (Lehmann et nl, 1992) . 1 ,25-Dihydroxyvitamin 0 3 is a ligand for VDR and induces the expression of VDR-responsive genes through its cognate nuclear receptor. To determ.ine the receptor specificities of TIG2 expression, skjn rafts were treated with RA1~-specific (Tazarotene), RXI~-specific (SR11217 and 61 120 
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Figure 2. Nucleotide and putative protein sequence ofTIG2 (Bl).
Bl eDNA clone was sequenced and analyzed by MacDNASIS (Hitachi, San Bruno, CA) program for open reading frames. Nucleotide and putative protein sequence of T!G2 as obtained from our subtracted eDNA library after sequencing two independent eDNA clones (B1 and B13) in both directions is shown. GenBank accession number, U77594. 
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-l. 00 -2 .00 -3.00 -4 . 00 Only the RAR-specific ligand significantly induced TIG2 expression (Fig 4D) , thus demonstrating tl1at the induction of TIG2 is mediated throu gh RAR but not by RXR or VDR agonistdependent signal transduction patl1ways.
Topical Application of Tazarotene (AGN 190168) Induces TIG2 Expression in Psoriatic Lesions To evaluate induction of TIG2 i11 JJ i JJo in psoriatic lesions, patients with long-standing plaque-type psoriasis were treated once daily with topical tazarotene gel (0.1 %) tor up to 8 wk. Skju-punch biopsies were taken before the treatm.ent and after 3 and 14 d of tazarotene treatment. A biopsy was also taken fi·om the nonlesional skjn of the psoriatic patients before start of treatment. A typical i11 sifr,, hybddization using rugoxigenin-labeled TIG2 anti-sense RNA showed intense staining for TIG2 mRNA expression in the epidermis of the nonlesionaJ skin biopsy of the psoriatic patient (Fig SA) , demonstratiJ1g that TIG2 is highly expressed in uninvolved psoriatic skjn. In nonlesional skjn, TIG2 was expressed in basal and suprabasal layers of the epidermis, hair follicles, and endothelial cells. A reduction in TIG2 expression was observed in the psoriatic lesion compared to nonlesional skin (Fig SB) . TIG2 was strongly induced in psoriatic lesions after 3 or 14 d of tazarotene treatment (Fig  SC,D) . Hybridization of psoriatic lesional section with sense d.igoxigen.in-labeled TIG2 RNA probe rud not show srai.njng ( Fig  SE) , thus demonstrating the speciftcity of TIG2 signal obtained w ith the anti-sense probe. The high expression of TIG2 message in uninvolved relative to lesional skin suggested that it may play a role in maintaining the normal physiology of skjn and tl1at of other tissues. Thus, various normal adult tissues were analyzed for TIG2 expression. Apart from skjn, TIG2 was also eJI.'Pressed in pancreas, liver, spleen, prostate, ovary, small intest:ll1e, and colon but not in heart, brain, placenta, lung, skeletal muscle, kjdney, thymus, testis, or peripheral blood
., ., . TIG2 is retinoid-inducible in a 3-dimensional culture system but not in 2-dimensional cnltures of keratittocytes and fibroblasts. Total RNA (10 p.g) from mock-treated (Control) or tazarotene-treated keratinocytes (A), fibroblasts (B), and keratinocytes (C) cultured in fibroblast-conditioned medium were subjected to northern blot hybridization. TIG2 and GAPDH sequences were detected with 32 P-labeled eDNA probes prepared by random priming. The oven:llght Phosphorlmager exposmes of the blots are presented. (D) TIG2 expression is induced in an RAR-ligand-dependent marmer. Total RNA (10 p.g) from mock-treated (Control) , tazarotene-, SR11217-, SR11237-, or 1,25-dihydrO>.]'Vita.min 0 3 -treated skin raft cultures was subjected to northern blot hybridization. TIG2 and GAPDH sequences were detected with labeled eDNA probes. leukocytes (Fig 6) , demonstrating the tissue-specific eli.'Pression of TIG2 in. llillo. GAPDH c ontrol of the multiple tissue northern blot is also shown.
Chromosomal Localization of TIG2 BLAST search of TIG2 eDNA sequence against luunan sequence tag site genornic clones database identified a clone (HSRSTS 367; GenBank accession number, Y07966) that displayed 100% nucleic acid homology over a stretch of 68 bp. The location of tlus STS clone fragment in the human genome maps the TIG2 gene to p13.3 region of chromosome 17. T herefore, TIG2 is located at 17p13.3 position . !J1terest-ingly, this region is associated with pancreatic tumorigenesis (for references, see GenBank accession number Y07966).
DISCUSSION
In tlus manuscript, we describe the identification of TIG2, a n e w retinoid-responsive gene. TIG2 was isolated by a subtraction hybridization approach aimed at identifying genes regulated by tazarotene, an RAR/3/-y-selective anti-psoriatic synthetic retinoid. TIG2 is induced in a retinoid-dependent manner in skin rafts and in the epidermis of p sot;atic lesions (Fig 1, 5) . m contrast, it was neither expressed nor induced by retinoids in 2-dimensional cultures of keratinocytes and fibroblasts (Fig 4) . Thus, TIG2 is a muque retinoid-responsive gene in that it is retinoid-inducible only when keratinocytes and fibroblasts form a 3-dimensional tissue T HE JOURNAL OF INVESTI GATIVE DERMATOLO GY structure as observed in skin rafts (Fig 1) and psoriatic lesions (Fig   5) . We also demonstrate that TIG2 expression is reduced in psoriatic lesions in comparison to nonlesional skin (Fig 5A,B) , suggesting that its expression may play a role in maintaining the normal phenotype of the skin . TIG2 expression was significantly induced in llillo in psoriatic lesions after 3 d or 2 wk of topical application of tazarotene (Fig 5C,D) . The early induction ofTIG2 expression in the epidermis of the psodatic lesion after tazarotene treatment, along with the observation that TIG2 was induced in skin rafts in a retinoid-dependent manner, suggest that the TIG2 induction is a result of direct effect of tazarotene on ke. ratinocyte gene expression rather than an overall tazarotene efi:ect on the lesional therapeutic status . Whether TIG2 is a marker of re tinoid efficacy in psoriasis can be determined only by elucidation of its biologic functions.
TIG2 was induced only by RAR and not by RXR or VDRspecific agonists (Fig 6) , although human keratinocytes contain E Figure 5 . Retinoid-dependent induction of TIG2 in psoriatic lesions. In situ hybridization using cligox:igenin labeled anti-sense TIG2 RNA probes was perfonned in nonlesional psoriatic skin (A ) , Jesional psoriatic skin (B) , or lesional psoriatic skin after a 3-d (C) or 14-d (D) treatment with topical tazarotene gel (0.1%). In situ control with retinoid-treated psoriatic skin probed with digox:igenin-label ed sense TJG2 probe was also performed (E). Scale bar, 100 p.m. Figure 6 . TIG2 is expressed iu various adult uormal hum au tissues.
T I G 2 -GAPDH-
TIG2 expression was analyzed in multiple tissue northern blots (CLON-TECJ-I, Pa lo Alto , CA) containing poly( A) + RNA from human heart, brain, placenta, lung, liver, skeletal muscle, kidney, pancreas, spleen, thymus, prostate, testis, ovary, small intestine, colon, and peripheral blood leukocytes.
tl-ese receptors in addition to R.ARs (Feldman eta/, 1980; Epstein and Bonifas, 1982; Fisher et al, 1994) . Similarly, TIG1 was also responsive to RAR agonists aJld not to RXR or VDR Hgands (Nagpal eta/, 1996; unpubHshed observations) . It is also surprising that inspite of its re lative abundance in skin, RXRs are not able to transduce the signals of RXR-specific ligands in skin and other systems reported (Gendimenico et al, 1994; Sheikh et a/, 1994; Nagpal et al, 1996) . RARs function i11 JJiJJo as RAR.-RXR heterodimers (Nagpal et a/, 1993) , and it appears that for TTG2 induction, only the occupation of the RAR ligand binding site of the heterodimer is required and that ligand binding to the R.XR site is ineffective. Altematively, the RXR ligand-binding site is not available for ligand binding as reported for RAR-RXR heterodimers on a DR.-5 DNA recognition motif (Kurokawa et al, 1994) . Further, the inactivity ofR.XR. ligands in TIG1 and TIG2 induction (Nagpal et al, 1996; Fig. 6) suggests that the RXl~ homodimer pathway (Zha11g et a/, 1992) is silent in skin.
CR.ABPIT is known to be an inducible marker of retinoid action in normal skin (Elder eta/, 1993) , but it is expressed at a high level in psoriatic skin and cultured keratinocytes (Didierjea11 et al, 1991 ; Elder and Cromie, 1993) . Further, its expression is inhibited by RA in cultured keratinocytes. These results suggest that in hyperproliferative or abnom1al differentiation states (as observed in psoriasis and cultured keratiJ1ocytes), another mechaJlism of CRABPIT regulation is domli1ant over its regulation by retinoids. Therefore, our previously discovered retinoid responsive gene TIG1 (Nagpal et al, 1996) and another novel gene TIG2 are the only genes known that are retinoid-inducible in psoriatic lesional skin.
At present w e can only speculate about the function ofTIG2 a11d its role in RAR-mediated biology. The presence of an N-termli1al hydrophobic sequence (Fig 3A) suggests that TIG2 is a membraneasso ciated protein. Therefore, TIG2 may play a role in cell-cell or cell-extracellular matrix interaction. The putative protein sequence ofTIG2 did not contaiJ1 calcium binding or hyaluronic acid binding motifs . The high level of TIG2 expression in uninvolved skll1 relative to lesional psoriatic skll1 suggests that TIG2 may play a role in the maintenance of the normal physiology of the skin. The presence of T!G2 in various normal tissues including the pancreas (Fig 6) and the association of its genetic locus (17p13.3) with pm1creatic tumorigenesis (see GenBank accession number Y07966) suggests that it may play a role i.J1 the nomul physiology of other organs as w ell. The actual physiologic fw1etions of TIG2 and the relevance of its up-regu lation to the therapeutic activity of tazarotene in psoriasis should be addressed. The identification of retinoidresponsive molecular markers, such as TIG1 and TIG2, in psoriatic lesions are important first steps in understanding the m echanisms of retinoid action in psoriasis .
